Hallak JE
Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
ArticleIbogaine
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.
ArticleAyahuasca
Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020).
ArticleAyahuasca
Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects.
ArticlePsilocybin
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
ArticlePsilocybin
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.
ArticlePsychedelics
Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy.
ArticleAyahuasca
Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.
ArticlePsilocybin
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
ArticleAyahuasca
Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.
ArticleAyahuasca